GPC3 and hepatocellular carcinoma: Previous evidence suggests that elevated circulating GPC-3 levels may correlate with tumor presence and aggressiveness [18, 19], but its diagnostic and prognostic performance in patients with HCV-related cirrhosis with or without HCC following DAA treatment has not been defined.